What's new at Łukasiewicz – PORT?

With funding from the Ministry of Science and Higher Education, Dr. Paweł Sega is building the BioValid platform, which will enable the analysis of microorganisms at the single-cell level.

The Biobank Research Group has increased its biological sample collection by 500%, enabling the Population Diagnostics Center, led by Dr. hab. Patrycja Gazińska, to reach a key milestone in the P4Health project funded under Teaming for Excellence.

The Virtual Research Institute (WIB), operating within the structure of Łukasiewicz – PORT, is seeking partners for the commercialization of an innovative mRNA-based technology. The technology was developed by one of WIB’s research teams, and we are looking for a partner to help further develop and bring it to market.

Precision medicine is transforming diagnosis and treatment, requiring advanced molecular analysis, deep insight into disease mechanisms, and high-quality biological samples, making close collaboration between researchers, laboratories, and hospitals essential for implementing innovative therapies.

Can cancer cells exploit strategies known from parasite biology? Dr. Marek Wagner explores melanoma from an evolutionary perspective, highlighting how tumors may manipulate the immune system in ways reminiscent of parasites.

For more than a century, science believed that neurons were responsible for our thoughts, emotions, and memory. During Brain Awareness Week, we tell the story of astrocytes.

February 19 marks Polish Science Day –established on the anniversary of Nicolaus Copernicus’s birth and honoring the achievements of successive generations of researchers. At Łukasiewicz – PORT, we view Polish science within a broad international context.

“I follow wherever the data lead me,” says Dr. Vitor Cabral, who has spent years building his scientific expertise across disciplines and continents – from classical microbiology and genetics, through infection biology, to synthetic biology and translational research. Today, at Łukasiewicz – PORT, he draws on this interdisciplinary background to design microbiome-based therapeutic strategies.

The fourth call of the Virtual Research Institute (WIB) has been resolved. An international panel of experts awarded the highest score to the project “Personalized antibody-drug conjugates activated by matrix metalloproteinases for solid tumors (PACMAN)”, submitted by a consortium of scientific institutions from Wrocław and Warsaw. An amount of PLN 72,854,995 from the Polish Science Fund has been allocated for its implementation.

Dr. Heng-Chang Chen, leader of the Quantitative Virology Research Group at Łukasiewicz – PORT, has been selected for the prestigious New Voices in Virology program by the Journal of Virology. The initiative showcases researchers who bring fresh perspectives and innovative methods to modern virology.